Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

Ovarian Reserve Clinical Trial

Official title:

Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03896243
• Other study ID #: uterinarter
• Status: Completed
• Start date: January 1, 2018
• Est. completion date: February 1, 2019

Study information

• Verified date: March 2019
• Source: Kanuni Sultan Suleyman Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Investigators would like to see the amh values after uterine artery ligation

Description:

Group/cohort:

Uterine artery ligation (UAL) Investigators would like to invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.

Participants would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Control Group:

Investigators would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication.

Participants would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Recruitment information / eligibility

• Status: Completed
• Enrollment: 102
• Est. completion date: February 1, 2019
• Est. primary completion date: January 1, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• age 18- 35 years

• no systemic or endocrine diseases

• patients who had uterine artery ligation due to atony

• healthy postpartum patients as controls

Exclusion Criteria:

• patients with PCOS

• Pregnancy with IVF or oosit donation

• Patients with endocrinopathy, diseases which require radiotherapy and chemotherapy etc.

• Patients with BMI >40

Related Conditions & MeSH terms

• Ovarian Reserve
• Uterine Artery Ligation

Intervention

Diagnostic Test:
• Uterine artery ligation (UAL)
Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Locations

Country	Name	City	State
Turkey	Pinar Yalcin Bahat	Istanbul	I?stanbul

Sponsors (1)

Lead Sponsor	Collaborator
Kanuni Sultan Suleyman Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	1.ovarian reserve in patients with uterine artery ligation	calculation of ovarian reserve with amh (ng/ml) after uterine artery ligation due to uterine atony	12 months